Bioventus (BVS) EBIT Growth (3y) (2023 - 2026)
Bioventus (BVS) EBIT Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 13.06% |
| 10 | Bioventus | 968.49 Mn | 939.04 Mn | 105.67 Mn | 41.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 41.51% |
| Mar 28, 2026 | 27.88% |
| Dec 31, 2025 | 48.07% |
| Sep 27, 2025 | 27.83% |
| Jun 28, 2025 | 96.20% |
| Mar 29, 2025 | 30.59% |
| Dec 31, 2024 | 64.43% |
| Sep 28, 2024 | 76.34% |
| Jun 29, 2024 | -76.34% |
| Mar 30, 2024 | -39.27% |
| Dec 31, 2023 | -41.79% |
| Sep 30, 2023 | -29.61% |
| Jul 1, 2023 | 51.39% |
| Apr 1, 2023 | -108.68% |